Arlington Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.22M | Buy |
25,453
+378
| +2% | +$129K | 1.17% | 23 |
|
|
2026
Q1 | $8.82M | Sell |
25,075
-724
| -3% | -$258K | 1.26% | 23 |
|
|
2025
Q4 | $8.44M | Buy |
25,799
+444
| +2% | +$141K | 1.21% | 25 |
|
|
2025
Q3 | $7.16M | Buy |
25,355
+471
| +2% | +$137K | 1.05% | 27 |
|
|
2025
Q2 | $6.95M | Sell |
24,884
-1,363
| -5% | -$386K | 1.14% | 24 |
|
|
2025
Q1 | $8.18M | Buy |
26,247
+2,416
| +10% | +$713K | 1.44% | 24 |
|
|
2024
Q4 | $6.21M | Sell |
23,831
-945
| -4% | -$280K | 1.24% | 25 |
|
|
2024
Q3 | $7.98M | Sell |
24,776
-171
| -0.7% | -$55.9K | 1.64% | 20 |
|
|
2024
Q2 | $7.79M | Sell |
24,947
-747
| -3% | -$219K | 1.71% | 20 |
|
|
2024
Q1 | $7.31M | Buy |
25,694
+261
| +1% | +$76.4K | 1.6% | 20 |
|
|
2023
Q4 | $7.33M | Sell |
25,433
-17
| -0.1% | -$4.63K | 2.19% | 14 |
|
|
2023
Q3 | $6.84M | Sell |
25,450
-161
| -0.6% | -$40.2K | 2.42% | 12 |
|
|
2023
Q2 | $5.69M | Buy |
25,611
+210
| +0.8% | +$48.7K | 2.07% | 13 |
|
|
2023
Q1 | $6.14M | Sell |
25,401
-869
| -3% | -$213K | 2.37% | 11 |
|
|
2022
Q4 | $6.9M | Buy |
26,270
+117
| +0.4% | +$31.4K | 2.91% | 10 |
|
|
2022
Q3 | $5.89M | Sell |
26,153
-1,287
| -5% | -$312K | 2.99% | 8 |
|
|
2022
Q2 | $6.68M | Buy |
27,440
+317
| +1% | +$77.7K | 3% | 9 |
|
|
2022
Q1 | $6.56M | Buy |
27,123
+12,680
| +88% | +$2.91M | 2.49% | 11 |
|
|
2021
Q4 | $3.25M | Sell |
14,443
-11,394
| -44% | -$2.4M | 1.1% | 30 |
|
|
2021
Q3 | $5.49M | Buy |
25,837
+113
| +0.4% | +$26K | 2.15% | 12 |
|
|
2021
Q2 | $6.27M | Buy |
25,724
+1,962
| +8% | +$483K | 2.38% | 11 |
|
|
2021
Q1 | $5.91M | Buy |
23,762
+746
| +3% | +$178K | 2.4% | 12 |
|
|
2020
Q4 | $5.29M | Buy |
23,016
+521
| +2% | +$120K | 2.23% | 13 |
|
|
2020
Q3 | $5.72M | Buy |
22,495
+8,884
| +65% | +$2.2M | 2.93% | 9 |
|
|
2020
Q2 | $3.21M | Hold |
13,611
| – | – | 1.81% | 19 |
|
|
2020
Q1 | $2.76M | Sell |
13,611
-320
| -2% | -$69.9K | 1.96% | 15 |
|
|
2019
Q4 | $3.36M | Sell |
13,931
-920
| -6% | -$203K | 1.87% | 17 |
|
|
2019
Q3 | $2.87M | Sell |
14,851
-145
| -1% | -$27.8K | 1.64% | 19 |
|
|
2019
Q2 | $2.76M | Hold |
14,996
| – | – | 1.58% | 20 |
|
|
2019
Q1 | $2.85M | Hold |
14,996
| – | – | 1.62% | 19 |
|
|
2018
Q4 | $2.92M | Hold |
14,996
| – | – | 1.24% | 26 |
|
|
2018
Q3 | $2.9M | Buy |
14,996
+292
| +2% | +$57.5K | 1.74% | 18 |
|
|
2018
Q2 | $2.89M | Buy |
+14,704
| New | +$2.6M | 1.68% | 18 |
|
Other funds holding AMGN
FFM
SP
Arlington Financial Advisors's AMGN Position: Q2 2026 in Review
Arlington Financial Advisors increased its Amgen (AMGN) stake by 1.5% in Q2 2026, buying an estimated $129K and bringing the position to 25,453 shares worth $9.22M. The position accounts for 1.17% of the portfolio, ranked #23.
Arlington Financial Advisors first reported a position in AMGN in Q2 2018 and has held it in 33 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Arlington Financial Advisors held 25,453 shares of Amgen worth $9.22M as of Q2 2026.
- Arlington Financial Advisors bought 378 Amgen shares in Q2 2026, an estimated $129K.
- Amgen made up 1.17% of Arlington Financial Advisors's portfolio in Q2 2026, its #23 holding.
- Arlington Financial Advisors first reported a position in Amgen in Q2 2018 and has held it in 33 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Arlington Financial Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.